Amanote Research

Amanote Research

    RegisterSign In

CD83 Polymorphisms and Cervical Cancer Risk

Gynecologic Oncology - United States
doi 10.1016/j.ygyno.2009.04.033
Full Text
Open PDF
Abstract

Available in full text

Categories
GynecologyOncologyObstetrics
Date

August 1, 2009

Authors
Kelly J. YuJanet S. RaderIngrid BoreckiZhengyan ZhangAllan Hildesheim
Publisher

Elsevier BV


Related search

An Updated Meta-Analysis: Cervical Cancer Risk Conferred by GSTM1 and GSTT1 Polymorphisms

International Journal of Sciences
2017English

Immuno-Related Polymorphisms and Cervical Cancer Risk: The IARC Multicentric Case-Control Study

PLoS ONE
Multidisciplinary
2017English

ERCC2/XPD Polymorphisms and Lung Cancer Risk

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2011English

Association of TAP Gene Polymorphisms and Risk of Cervical Intraepithelial Neoplasia

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2013English

MicroRNA Polymorphisms and Risk of Colorectal Cancer

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2014English

Genetic Polymorphisms and Head and Neck Cancer Risk (Review)

International Journal of Oncology
Cancer ResearchOncology
2008English

AKNA as Genetic Risk Factor for Cervical Intraepithelial Neoplasia and Cervical Cancer

2012English

Breast Cancer Risk, Nightwork, and Circadian Clock Gene Polymorphisms

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2014English

DNA Repair Gene XRCC1 Polymorphisms and Bladder Cancer Risk

BMC Genetics
Genetics
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy